Tech Company Financing Transactions

Tyton BioSciences Funding Round

Tyton BioSciences, operating out of Danville, scored $8 million in investment from Tin Shed Ventures, Alante Capital and Card Sound Capital.

Transaction Overview

Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Proceeds Purpose
The funding will be used to scale the solution and accelerate entry into the market.

Company Information

Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
300 Ringgold Industrial Pkwy.
Danville, VA 24540
USA
Email Address
Not Recorded
Overview
The late Dr. Hilary Koprowski, one of Tyton's co-founders, always said that if you are going to try to solve a problem, make it a big one. Our company lives this statement every day as we work to tackle big issues related to environmental sustainability with economics that make sense.
Profile
Tyton BioSciences LinkedIn Company Profile
Social Media
Tyton BioSciences Company Twitter Account
Company News
Tyton BioSciences News
Facebook
Tyton BioSciences on Facebook
YouTube
Tyton BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Ed Scott
  Ed Scott LinkedIn Profile  Ed Scott Twitter Account  Ed Scott News  Ed Scott on Facebook
Chief Executive Officer
Peter Majeranowski
  Peter Majeranowski LinkedIn Profile  Peter Majeranowski Twitter Account  Peter Majeranowski News  Peter Majeranowski on Facebook
Chief Financial Officer
Luke Henning
  Luke Henning LinkedIn Profile  Luke Henning Twitter Account  Luke Henning News  Luke Henning on Facebook
Chief Technical Officer
Iulian Bobe
  Iulian Bobe LinkedIn Profile  Iulian Bobe Twitter Account  Iulian Bobe News  Iulian Bobe on Facebook
VP - Bus. Development
Conor Hartman
  Conor Hartman LinkedIn Profile  Conor Hartman Twitter Account  Conor Hartman News  Conor Hartman on Facebook
VP - R & D
Sean Su
  Sean Su LinkedIn Profile  Sean Su Twitter Account  Sean Su News  Sean Su on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/13/2020: Aligos Therapeutics venture capital transaction
Next: 1/13/2020: Generation Bio venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary